CXCL12 and neoplasm: Accordingly, administering an inhibitor of CXCR4, the receptor for CXCL12, to the PDA-bearing mice led to the rapid accumulation of effector T cells within the tumor and blockage IL-6 could improve T-cell trafficking, migration and tumor immunosuppression (117).